Bayer’s Cancer Research Amidst Concerns over Glyphosate Safety: Balancing Corporate Interests with Public Health

Bayer, the company behind the herbicide glyphosate, is currently conducting research on a treatment for cancer that it may have caused. However, this comes at a time when there are concerns about the chemical’s safety and its potential link to cancer. Studies have shown elevated cancer biomarkers in individuals with high glyphosate concentrations, and the World Health Organization has stated that glyphosate is likely carcinogenic to humans.

As a result of these findings, legislation is being considered in Iowa that would limit individuals’ ability to seek damages for harm caused by glyphosate. This move by the GOP raises questions about prioritizing corporate interests over public health. With issues like nitrogen pollution and damage from liquefied gas already affecting Iowans, it is clear that science should be respected and prioritized over business interests in policymaking.

Sonia Ettinger brings attention to this issue and urges legislators to consider the scientific evidence and prioritize public health in their decision-making processes. It is crucial to listen to experts in the field and protect the well-being of Iowans. The opinions expressed in this content reflect the views of the author or The Gazette editorial board, and readers are encouraged to engage in the conversation by submitting their own letters or columns on the topic.